SLB:NYSESLB Limited Analysis
Data as of 2026-03-10 - not real-time
$47.19
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical momentum remains bullish as the short‑term moving average stays above the medium‑term average, while price hovers near a well‑defined support zone. Relative strength is approaching oversold territory and the MACD histogram is negative, suggesting a potential short‑term rebound.
Fundamental backdrop shows a price that is well above the discounted cash‑flow estimate and the consensus target, indicating an overvalued market level. The company’s dividend yield is attractive and the payout ratio is comfortably below the half‑of‑earnings threshold, supporting dividend sustainability. Recent news of a multi‑billion‑dollar contract in the Middle East adds a fresh catalyst, but the high debt load, elevated volatility, and sector‑specific regulatory headwinds temper enthusiasm.
Fundamental backdrop shows a price that is well above the discounted cash‑flow estimate and the consensus target, indicating an overvalued market level. The company’s dividend yield is attractive and the payout ratio is comfortably below the half‑of‑earnings threshold, supporting dividend sustainability. Recent news of a multi‑billion‑dollar contract in the Middle East adds a fresh catalyst, but the high debt load, elevated volatility, and sector‑specific regulatory headwinds temper enthusiasm.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- New multi‑billion contract providing near‑term revenue boost
- Price near technical support with bullish moving‑average alignment
- Oversold momentum indicator suggesting upside potential
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Current market price exceeds intrinsic valuation estimates
- Attractive dividend yield offset by high leverage
- Energy‑sector cyclicality and moderate regulatory pressure
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Long‑term energy transition could pressure oilfield services demand
- Elevated debt‑to‑equity ratio limits financial flexibility
- Sustainable dividend provides a defensive income component
Key Metrics & Analysis
Financial Health
Revenue Growth5.00%
Profit Margin9.45%
P/E Ratio20.0
ROE13.90%
ROA6.77%
Debt/Equity45.98
P/B Ratio2.7
Op. Cash Flow$6.5B
Free Cash Flow$2.4B
Industry P/E20.6
Technical Analysis
TrendBullish
RSI39.6
Support$45.50
Resistance$52.45
MA 20$50.20
MA 50$47.49
MA 200$38.29
MACDBearish
VolumeStable
Fear & Greed Index75.89
Valuation
Fair Value$22.59
Target Price$55.55
Upside/Downside17.71%
GradeOvervalued
TypeValue
Dividend Yield2.52%
Risk Assessment
Beta1.15
Volatility32.32%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.